Searchable abstracts of presentations at key conferences in endocrinology

ea0033oc2.2 | Oral Communications 2 | BSPED2013

Increased bone area without reduction in volumetric bone mineral density in children treated with glucocorticoids for nephrotic syndrome

Moon Rebecca , Gilbert Rodney , Murphy Liam , Page Anna , Taylor Pat , Cooper Cyrus , Dennison Elaine , Davies Justin

Background: Glucocorticoids are frequently used to treat childhood inflammatory disorders, and may cause increased fracture predisposition with reduced bone mineral density (BMD), particularly from trabecular bone loss. The contribution of the underlying inflammatory disease processes to these outcomes is poorly understood. Childhood nephrotic syndrome (NS) is a useful model to investigate the effects of steroids on bone, as recurrent courses are often required, but systemic i...